Christoph H. Westphal, President and CEO at Flex Pharma, Inc. (FLKS), bought 7,000 shares at $7.31 ($51K) on 2016-11-08, disclosed to the SEC on 2016-11-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| FLKS | BUY | 2016-11-07 | $51K | — | Filing → |
| FLKS | BUY | 2016-06-24 | $30K | — | Filing → |
| FLKS | BUY | 2016-06-22 | $63K | — | Filing → |